Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-5-8
pubmed:abstractText
Medical care of patients with essential hypertension implies considerable expenses for the National Health System (NHS). During the performance of clinical trials (CT), the promoter (usually the pharmaceutical industry) covers the expenses of patient care, which implies savings for the NHS. In this work, we quantitated cost savings derived from the participation of patients in clinical trials on essential hypertension in a tertiary care level Insalud hospital.
pubmed:language
spa
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0014-2565
pubmed:author
pubmed:issnType
Print
pubmed:volume
202
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
66-72
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Cost savings derived from the participation in clinical trials].
pubmed:affiliation
Servicio de Medicina Interna, Hospital La Paz, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain. jgarciapuig@navegalia.com
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract, Randomized Controlled Trial, Research Support, Non-U.S. Gov't